-
NICE SEVERITY MODIFIER LEVELS AND CORRESPONDING REIMBURSEMENT PATHWAYS FOR ANTICANCER THERAPIES IN SOUTH KOREA: A DESCRIPTIVE ANALYSIS
Aug 11, 2026, 17:16 PM -
ECONOMIC EVALUATION OF A FIXED-DOSE INTRANASAL KETAMINE AND SUFENTANIL COMBINATION FOR PEDIATRIC ACUTE PAIN IN SWEDEN
Aug 11, 2026, 17:16 PM -
COMMUNITY-BASED VERSUS FACILITY-BASED DIRECTLY OBSERVED THERAPY FOR MULTIDRUG-RESISTANT TUBERCULOSIS IN UGANDA: A COST-UTILITY ANALYSIS
Aug 11, 2026, 17:16 PM -
STREAMLINED HTA IN THE UK: A COMPARATIVE ANALYSIS OF NICE'S PROPORTIONATE APPROACH AND SMC'S ABBREVIATED SUBMISSION PATHWAY
Aug 11, 2026, 17:16 PM -
WHOSE OUTCOMES? PATIENT INVOLVEMENT AND PATIENT-RELEVANT ENDPOINTS IN EU JOINT CLINICAL ASSESSMENT
Aug 11, 2026, 17:16 PM -
WEIGHT LOSS EFFECTIVENESS OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1RAS) WHEN USED WITH AND WITHOUT LIFESTYLE MODIFICATIONS: A RETROSPECTIVE REAL-WORLD STUDY
Aug 11, 2026, 17:16 PM -
SELECTIVE PROCESS SPILLOVER UNDER A DIABETES PAY-FOR-PERFORMANCE PROGRAM IN TAIWAN
Aug 11, 2026, 17:16 PM -
EXPANDED ACCESS-DERIVED REAL-WORLD EVIDENCE IN SUPPORT OF FDA REGULATORY REVIEW: A CASE STUDY IN INFANTILE-ONSET NIEMANN-PICK DISEASE TYPE C
Aug 11, 2026, 17:16 PM -
ASSESSING EQ-5D-5L AND 12 BOLT-ON DIMENSIONS AMONG MULTI-ETHNIC ASIANS WITH OBESITY WHO HAVE AND HAVE NOT RECEIVED BARIATRIC SURGERY IN SINGAPORE
Aug 11, 2026, 17:16 PM -
QUANTITATIVE INVESTIGATION OF BACKGROUND FACTORS OF CYBERCHONDRIA IN A YOUNG ADULT SAMPLE
Aug 11, 2026, 17:16 PM -
HEALTHCARE RESOURCE UTILIZATION AND COSTS OF NON-NAïVE PATIENTS INITIATING OCRELIZUMAB VERSUS MODERATE-EFFICACY TREATMENTS FOR MULTIPLE SCLEROSIS: 2-YEAR REAL-WORLD EVIDENCE FROM THE FRENCH OLIDIA STUDY
Aug 11, 2026, 17:16 PM -
ESTIMATING THE HEALTH AND ECONOMIC BURDEN OF SOCIOECONOMIC INEQUALITIES IN BREAST CANCER SCREENING: AN INDIVIDUAL-LEVEL MICROSIMULATION STUDY
Aug 11, 2026, 17:16 PM -
STRATEGIC LAUNCH SEQUENCING UNDER MFN - REASSESSING MARKET PRIORITIZATION BEYOND TRADITIONAL PRIORITY MARKETS
Aug 11, 2026, 17:16 PM -
CURRENT AND FUTURE ADOPTION OF ARTIFICIAL INTELLIGENCE BY EUROPEAN PAYERS
Aug 11, 2026, 17:16 PM -
MODERNIZING HYPERTENSION ECONOMIC MODELS: INCORPORATING PROGNOSTIC RISK MARKERS AND MULTIFACETED TREATMENT EFFECTS WITHIN THE BAX-HTN MODEL
Aug 11, 2026, 17:16 PM -
PATIENT AND CAREGIVER PREFERENCES FOR ORPHAN DRUG REIMBURSEMENT PRIORITIES IN CHINA: A DISCRETE CHOICE EXPERIMENT
Aug 11, 2026, 17:16 PM -
CLOSING THE LOOP IN HOSPITAL-BASED HTA: FROM ASSESSMENT TO REAL-WORLD OUTCOMES OF ADJUVANT OSIMERTINIB
Aug 11, 2026, 17:16 PM -
VITILIGO IN COLOMBIA (2021-2025): DEMOGRAPHIC PROFILE AND REGIONAL DISTRIBUTION FROM POPULATION-BASED ADMINISTRATIVE DATA (RIPS)
Aug 11, 2026, 17:16 PM -
DEVELOPMENT OF A VALUE ASSESSMENT MODEL FOR SHARED CLINICIAN-PATIENT DECISION-MAKING ON ANTINEOPLASTIC AGENTS IN CHINA: A DELPHI STUDY
Aug 11, 2026, 17:16 PM -
SELECTION AND USE OF PRIMARY ENDPOINTS IN ONCO-HEMATOLOGY: A DISEASE-SPECIFIC ANALYSIS OF CLINICAL EVIDENCE TO SUPPORT REGULATORY AND REIMBURSEMENT DECISIONS.
Aug 11, 2026, 17:16 PM
